Showing results (171-180 of 181) with videos related to
Sort By:
Pageof 19
JAMA Network Open|July 1, 2024
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older EuropeansCharlotte Laniece Delaunay, Clara Mazagatos, Iván Martínez-Baz, et al.Influenza and Other Respiratory Viruses|January 11, 2024
Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre studyMarine Maurel, Francisco Pozo, Gloria Pérez-Gimeno, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 23, 2021
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021Esther Kissling, Mariette Hooiveld, Virginia Sandonis Martín, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 29, 2024
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022Charlotte Lanièce Delaunay, Iván Martínez-Baz, Noémie Sève, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 23, 2024
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024Marine Maurel, Jennifer Howard, Esther Kissling, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 27, 2022
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021Esther Kissling, Mariëtte Hooiveld, Iván Martínez-Baz, et al.American Journal of Epidemiology|November 17, 2025
Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case studyEsther Kissling, Baltazar Nunes, Mariëtte Hooiveld, et al.Plos One|September 13, 2019
The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st centurySaverio Caini, Gabriela Kusznierz, Verònica Vera Garate, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 12, 2021
Re-emergence of enterovirus D68 in Europe after easing the COVID-19 lockdown, September 2021Kimberley Sm Benschop, Jan Albert, Andres Anton, et al.Influenza and Other Respiratory Viruses|November 29, 2023
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022Margaux M I Meslé, Mary Sinnathamby, Piers Mook, et al.Pageof 19